Amanote Research
Register
Sign In
Identification of Novel Genes Associated With a Poor Prognosis in Pancreatic Ductal Adenocarcinoma via a Bioinformatics Analysis
Bioscience Reports
- Netherlands
doi 10.1042/bsr20190625
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Date
August 1, 2019
Authors
Jun Zhou
Xiaoliang Hui
Ying Mao
Liya Fan
Publisher
Portland Press Ltd.
Related search
SERP1 Is a Novel Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients via Anti-Apoptosis and Regulating SRPRB/NF-κB Axis
International Journal of Oncology
Cancer Research
Oncology
Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
American Journal of Surgical Pathology
Anatomy
Forensic Medicine
Pathology
Surgery
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Mutations in BRCA1, BRCA2, and PALB2, and a Panel of 50 Cancer-Associated Genes in Pancreatic Ductal Adenocarcinoma
Scientific Reports
Multidisciplinary
Potential Four‑miRNA Signature Associated With T�stage and Prognosis of Patients With Pancreatic Ductal Adenocarcinoma Identified by Co‑expression Analysis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Identification of Key Candidate Genes for Pancreatic Cancer by Bioinformatics Analysis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
SIRT1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Surgical Outcomes in Octogenarians With Left-Sided Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis
HPB
Hepatology
Gastroenterology
